My firm just published our Spring 2008 Entrepreneurs Report, summarizing trends in the venture-backed technology market over the last several years. Among the statistics is this interesting chart showing the average founder equity dilution in Series A and Series B financings broken down by industry. The dilution numbers on the BioTech industry are up above 90%, meaning that by the end of the second round of financing founders of biotech companies don't own much of the company. The counter to this is that biotech projects require a greater degree of funding, and if you need to raise a lot of money, you aren't going to get it without giving up some equity.
Video site Omnisio.com has video synchronized with slides from Y Combinator's Startup School 2008. Some heavy hitters gave presentations, including Jeff Bezos, Marc Andreessen, and Jack Sheridan from WSGR.
I am prone to believe this even though it is April 1st, if anything because it would be an incredibly lame joke. Document sharing site, Scribd, has apparently rolled out a program offering to convert your paper to its iPaper format for free. You mail your documents to them, they [...]
From my office in the Columbia Tower I have a great view of the startup community, both literally and in the work that I do. From Pioneer Square to Fremont and beyond, there are exciting things brewing in Seattle. The following is This Is Tech's list of Seattle Startups to Watch in 2008. These emerging companies are bootstrapping some interesting stuff:
How Green Was My Valley | Redfin Corporate Blog: “How Green Was My Valley
The New York Times reports Friday that alone among all the cities hoping to be the next Silicon Valley, Seattle ‘is actually doing it.’
But the Times didn’t talk to iLike President Hadi Partovi, or Zillow.com CEO Rich Barton, both entrepreneurs who, like [...]
Wednesday, June 18, 2008
0 Comments